Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
39results about How to "Improve pathological condition" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Fu moxibustion traditional Chinese pharmaceutical oil and preparation method thereof
InactiveCN106215157AReach activityAchieve anti-inflammatory and pain-relieving effectNervous disorderAntipyreticAlcoholEucalyptus oil
The invention provides Fu moxibustion traditional Chinese pharmaceutical oil and a preparation method thereof. The traditional Chinese pharmaceutical oil is prepared from the following raw materials in parts by weight: 2 to 8 parts of cortex cinnamomi oil, 5 to 10 parts of wintergreen oil, 5 to 10 parts eucalyptus oil, 1 to 5 parts of mint oil, 1 to 5 parts of rose oil, 1 to 5 parts of lavender oil, 2 to 8 parts of rhizoma acori graminei oil, 2 to 8 parts of clove oil, 1 to 5 parts of ginger oil, and 2 to 8 parts of ethyl alcohol. The Fu moxibustion traditional Chinese pharmaceutical oil has the effects of dispelling the wind, invigorating the blood circulation, dispelling cold, diminishing inflammation, relieving pain, quieting the heart, soothing the nerves and calming. Based on the yin-yang theory in the traditional Chinese medicine theory, the drug effects can be quickly played through exhaling, exterior syndrome relieving and warming of the externally applied drug. Due to the action of the ethyl alcohol, the drug can quickly penetrate through skin and permeate into muscular striae, and the effects of dispelling the wind, invigorating the collateral, diminishing inflammation and relieving pain can be obtained. The kind of medium medicine can dispel cold through warmness to achieve the effects of dispelling the wind, removing cold, clearing heat, diminishing inflammation, invigorating the blood circulation, activating meridians and relieving pain.
Owner:张东旭
Application of chlorogenic acid in preparation of medicines for treating parkinson disease
InactiveCN104644624AHas a therapeutic effectSymptoms improvedOrganic active ingredientsNervous disorderChlorogenic acidMidbrain
The invention discloses an application of chlorogenic acid in preparation of medicines for treating a parkinson disease. The chlorogenic acid is beneficial to reduction of the toxicity of substantia nigra and striatum neurons and activation of the autophagy activity of substantia nigra and striatum neurons in a midbrain, beneficial to adjustment of blood ketone content of a parkinson disease mice model, and beneficial to inhibition of apoptosis of substantia nigra cells in the parkinson disease mice model, and plays positive improvement and treatment roles in symptoms, pathology and the like of the parkinson disease.
Owner:SICHUAN JIUZHANG BIO TECH CO LTD
Lucid ganoderma and grifola frondosa blood sugar-lowering composition, and preparation method and use thereof
InactiveCN110559332AGood hypoglycemic effectImprove coordinationMetabolism disorderFungi medical ingredientsAdditive ingredientBitter gourd
The present invention relates to a composition and particularly discloses the blood-sugar-lowering composition prepared from lucid ganoderma, grifola frondosa and bitter gourds as main raw materials,a preparation method and a use thereof. The composition comprises the following raw materials in weight percentages: 20-40% of lucid ganoderma, 40-60% of grifola frondosa and 10-30% of bitter gourds.Beneficial effects are as follows: (1) the blood-sugar-lowering composition has characteristics of being natural and safe; and at the same time, edible fungi are mixed with natural hypoglycemic substances, effects of each of the various raw materials on hypoglycemic effects are fully exerted, and the composition has a good hypoglycemic coordination function; (2) microfiltration and ultrafiltrationretention technology used in the preparation method has characteristics of simple operation, low energy consumption, short production cycle, etc., maximally separates and protects the active ingredients in an extract of grifola frondosa, and removes less effective ingredients; and (3) animal experiments show that the composition is significant in hypoglycemic effect.
Owner:GUANGDONG YUEWEI BIOLOGICAL TECH CO LTD
Traditional Chinese medicine composition for treating osteoporosis
InactiveCN106938005AEliminate triggersImprove pathological conditionSkeletal disorderMolluscs material medical ingredientsSide effectOyster
The invention belongs to the technical field of traditional Chinese medicines and relates to a traditional Chinese medicine composition for treating osteoporosis. The traditional Chinese medicine composition is composed of 5 to 15 portions by weight of red deer bone, 5 to 15 portions by weight of drynaria rhizome, 5 to 15 portions by weight of bark of eucommia, 5 to 15 portions by weight of ginseng, 5 to 15 portions by weight of radix astragali, 5 to 15 portions by weight of prepared rehmannia root, 5 to 15 portions by weight of rhizoma polygonati, 5 to 15 portions by weight of Chinese wolfberry, 5 to 15 portions by weight of epimedium, 5 to 15 portions by weight of fructus psoraleae, 5 to 15 portions by weight of pseudo-ginseng and 5 to 15 portions by weight of calcined oyster. The composition realizes a low raw material cost, is easy to use, is practical, can effectively treat osteoporosis and has small side effects.
Owner:LIAONING UNIV OF TRADITIONAL CHINESE MEDICINE
Application of angelica peony powder in preparation of drugs for treating cirrhosis ascites
InactiveCN102727681ATo promote metabolismRelief formationDigestive systemBlood disorderLiver tissueLiver function
The present invention provides an application of angelica peony powder in preparation of drugs for treating cirrhosis ascites. With the angelica peony powder of the present invention, indicators of TBIL, ALT and AST of cirrhosis ascites rats can be significantly reduced, ALB can be increased, A / G ratio inversion is improved, liver cell metabolism is improved, liver function is improved, and liver protection is achieved; and a liver fibrosis pathological state is improved, and pseudolobule formation is slowed so as to prevent cirrhosis formation. With combination of the angelica peony powder and V2 receptors of distal convoluted tubules and collecting ducts of kidney, water reabsorption of kidney collecting ducts is inhibited. In addition, with the angelica peony powder of the present invention, AQP4 expression in liver tissues is unregulated, ascites transportation is prompted, and cirrhosis ascites generation is reduced so as to provide treatment effects for cirrhosis ascites.
Owner:ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Uses of cycloastragenol in preparation of chronic renal failure treatment drugs
PendingCN106943410ADefinite curative effectFully functionalOrganic active ingredientsUrinary disorderPharmaceutical drugAglycone
The present invention belongs to the field of medicine, and particularly relates to uses of cycloastragenol in preparation of chronic renal failure treatment drugs. According to the present invention, cycloastragenol is the aglycone of astragaloside A, and has advantages in biological membrane permeation and gastrointestinal tract absorption compared to astragaloside A due to the relatively small molecular weight and the strong lipophilicity, and the test results show that cycloastragenol can change various physiologic indexes of chronic renal failure rates so as to provide great application prospects in the treatment of chronic renal failure.
Owner:LUNAN PHARMA GROUP CORPORATION
Antifungal composition comprising antifungal peptide and terpene alcohol
InactiveUS20170354177A1Improve securityImprove and treat pathological conditionCosmetic preparationsAntimycoticsAlcoholHydrolysate
A composition with an enhanced antifungal activity, which comprises peptides as a protamine hydrolysate and which is suitable for industrial application at a low cost, can be provided, by using a combination of a protamine hydrolysate and a terpene alcohol as an active ingredient of a composition having an antifungal activity.
Owner:MARUHA NICHIRO +1
Chinese medicinal composition for treating fallopian tube obstruction and preparation method thereof
InactiveCN101744921AFast absorptionPromote absorptionAnthropod material medical ingredientsSuppositories deliveryCentipedePatrinia
The invention relates to a Chinese medicinal composition for treating fallopian tube obstruction and a preparation method thereof. The Chinese medicinal composition comprises Chinese angelica, Chinese honeylocust spine, ground beeltle, pangolin scales, beautiful sweetgum fruit, safflower, peach seed, dahurian patrinia herb, towel gourd vegetable sponge, bupleurum, earthworm, tangerine leaf, sanchi, raidx astragali, sanguisuge, immature bitter orange, centipede, diverse wormwood herb, heterophylly falsestarwort root and hiraute shiny bugleweed herb. The Chinese medicinal composition of the invention has reasonable compatibility and can be prepared into various oral preparations or external preparations clinically according to the Chinese medicinal common preparation method, and particularly has the advantages of quick absorption and high utilization degree of the crude drugs when being matched with rectal administration. Moreover, the medicament can promote blood and lymph circulation to accelerate by warming application to increase vascular permeability and improve the nutrition metabolism of tissues, promote the absorption of the inflammatory substances and achieve the effects on spasmolysis and antiphlogosis. Moreover, when being matched with the auricular therapy, the Chinese medicinal composition can adjust the function of the hypothalamic-hypophyscal-ovarian axis, improve the pathological state and recover the normal reproduction physiology function.
Owner:赵子山
Sanqi dampness-eliminating formula and application thereof
ActiveCN114558094AIncrease appetiteIncrease weightAnthropod material medical ingredientsUrinary disorderDoxorubicinAtractylis ovata
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a radix astragali, radix notoginseng and radix astragali dampness-clearing formula and application thereof, and the radix astragali, radix notoginseng and radix astragali dampness-clearing formula comprises the following raw material medicines in parts by weight: 15-60 parts of radix astragali, 5-10 parts of radix notoginseng, 5-15 parts of rhizoma curcumae, 5-15 parts of radix paeoniae rubra, 5-20 parts of rhizoma atractylodis macrocephalae, 10-20 parts of cordyceps sobolifera and 10-30 parts of rhizoma smilacis glabrae. The invention also provides application of the Sanqi dampness-eliminating formula. Clinical tests show that the Sanqi dampness-clearing prescription can significantly improve the remission rate of a patient with membranous nephropathy, and when the Sanqi dampness-clearing prescription is combined with an immunosuppressive agent to treat membranous nephropathy, the curative effect is obvious, and the safety is good. Animal experiments show that the Sanqi dampness-clearing formula can improve general conditions such as appetite, body weight, activity, mental state, hair, hair color, urination and defecation of doxorubicin-induced nephrotic syndrome rats; the urine protein level of rats can be reduced to a certain extent; the pathological state of the rat kidney tissue is improved.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Injection injected into acupoint Houhai to treat piglet diarrhea
InactiveCN103007270AAnti-inflammatoryFunctionalAntibacterial agentsOrganic active ingredientsProcaineDexamethasone
The invention provides an injection injected into an acupoint Houhai to treat piglet diarrhea. Every 100ml of the injection contains the following raw medicines: 2% procaine*(18-22)mL, ceftiofur sodium (0.5g / bottle)*(22-28) bottles, Newcastle disease IV (1000 feathers), dexamethasone (2mg / mL)*(18-22)mL and the balance of physiological saline. Compared with the existing treatment medicines, the injection injected into the acupoint Houhai of piglets to treatment diarrhea has higher cure rate and reduces the treatment cost by 20%.
Owner:蚌埠市畜牧兽医技术推广站
Methotrexate-entrapped iron-tannic acid complex, and preparation method and application thereof
ActiveCN111821470AThe preparation process is simple and controllableIncrease savingsPowder deliveryOrganic active ingredientsOrganic solventMethotrexate
The invention relates to the technical field of biological medicines, in particular to a methotrexate-entrapped iron-tannic acid complex and a preparation method and application thereof. Methotrexateand tannic acid in the complex are covalently coupled to form a drug-organic ligand bond, the drug-organic ligand bond is coordinated with Fe<3+> to form the methotrexate-entrapped iron-tannic acid complex, and then a targeting ligand and the complex are combined through electrostatic interaction to form the targeting complex. The complex does not need to be added with other carrier materials, organic solvents and the like, the preparation process is simple, controllable, green and safe, and the drug is efficiently delivered to an inflammatory joint part under the dual mediation of passive targeting and active targeting, so that the complex is used for treating rheumatoid arthritis.
Owner:CENT SOUTH UNIV
Control method of physiotherapy instrument
The invention discloses a control method of a physiotherapy instrument. The control method comprises the following steps: the physiotherapy instrument receives a starting instruction; the physiotherapy instrument outputs a first physiotherapy instruction and inputs a first physiotherapy signal to a first output end and inputs a second physiotherapy signal to a second output end; the physiotherapy instrument outputs a second physiotherapy instruction, inputs the first physiotherapy signal to the second output end and inputs the second physiotherapy signal to a third output end; and so on; the physiotherapy instrument outputs a (n-1)th physiotherapy instruction, inputs the first physiotherapy signal to a (n-1)th output end and inputs the second physiotherapy signal to an nth output end. The control method of the physiotherapy instrument is suitable for meridian therapy, controls the physiotherapy instrument with multiple output ends to circularly and orderly inputs the physiotherapy signals to the output ends so as to dredge main and collateral channels of a physiotherapy object, so that the physiotherapy efficiency can be improved, the dredging and physiotherapy effect of the main and collateral channels can be improved, and the human body function of the physiotherapy object can be effectively regulated and controlled.
Owner:李福军
High-affinity anti-cyclic citrullinated peptide tetravalent micro-molecule antibody and preparation method and application thereof
ActiveCN110272497AHigh expressionRemove space barriersAntipyreticAntibody mimetics/scaffoldsAnti ccp antibodiesScFv Antibodies
The present invention relates to a high-affinity anti-cyclic citrullinated peptide single-chain variable region tetravalent micro-molecule antibody. The invention proves that an anti-CCP antibody is not only a serologic marker for RA diagnosis, but also plays an important role in RA pathogenesis, and provides a test basis for RA targeted therapy with a citrullinated antigen as a target. In the present invention, a CCP epitope is used as a therapeutic target and an entry point. The research content involves multiple levels at which the CCP may be involved in the RA pathogenesis, so as to systematically and comprehensively reveal the role of the anti-CCP antibody in the RA pathogenesis. The peptide chain of an anti-CCP- ScFv antibody and a tetramer antibody with a P53 framework used in the invention are completely humanized sequences, acted on and targeted to an initiation of the RA pathogenesis and chronic process of inflammation, so as to have more pertinence. Different from existing downstream inflammatory response mediators and inflammatory signaling pathway mediators that antagonize the RA pathogenesis, the high-affinity anti-cyclic citrullinated peptide tetravalent micro-molecule antibody of the invention has more leading and accurate targetability of the target, and has better potential for transformation of technological achievements and prospect for biopharmaceutical development. In addition, an anti-CCP+RA and an anti-CCP-RA targeted by the high-affinity anti-cyclic citrullinated peptide tetravalent micro-molecule antibody of the invention may be two different disease subtypes of the RA, so that the antibody may become a new hope for accurately targeted therapy for such patients.
Owner:内蒙古医科大学附属医院
Traditional Chinese medicine composition for treating hypertensive heart failure
ActiveCN108143800AImprove pathological conditionLower systolic blood pressureCardiovascular disorderPlant ingredientsBiopharmacologyCompounded preparations
The invention discloses a traditional Chinese medicine composition for treating hypertensive heart failure and belongs to the field of traditional Chinese medicine. Active pharmaceutical ingredients of the traditional Chinese medicine composition include caulis spatholobi, pseudo-ginseng, root of red-rooted salvia, radix astragali and exocarpium. The traditional Chinese medicine composition conforms to theories of modern systematic pharmacology, and selected medicine has clear ingredients and can act on disease targets of hypertension and heart failure at the same time; the composition also accords with conventional traditional Chinese medicine dialectical theory systems and monarch, minister, assistant and guide combination principles of traditional Chinese medicine. In-vivo experiment results show that the composition can effectively lower systolic pressure of spontaneously hypertensive rats SHR and is slightly less than positive control medicine captopril in effect; the compositioncan increase ejection fraction and shortening fraction of SHR hearts and is better than captopril in treatment effect. The composition is few in herbal medicine, accurate and reliable in treatment effect and clear in main medicinal ingredient, non-medicinal factors in traditional Chinese medicine compound preparations can be reduced, and preparation level is improved.
Owner:SOUTHERN MEDICAL UNIVERSITY
Hydro lifting instrument injection umbilical cord mesenchymal stem cell preparation and application thereof
InactiveCN109646459AImprove textureImprove skin toneCell dissociation methodsPharmaceutical delivery mechanismStem cell productMesenchymal stem cell
The invention discloses a hydro lifting instrument injection umbilical cord mesenchymal stem cell preparation and application thereof. The umbilical cord mesenchymal stem cell preparation is a stem cell suspension composed of umbilical cord mesenchymal stem cells and normal saline, wherein the total volume of the umbilical cord mesenchymal stem cells and the normal saline is 5 ml, and the total number of umbilical cord mesenchymal stem cells in the dry cell suspension is 1*10<6>-10<7>. A 9-needle type hydro lifting injection instruction is adopted, on the basis of the vacuum negative pressuretechnology, average coverage is performed on each unit area (1 cm<2>) through the same dosage, it is a new breakthrough that traditional point filling is replaced with face filling, umbilical cord mesenchymal stem cells are injected into a skin corium layer through the hydro lifting injection instrument, fixed-point, quantified and fixed-layer injection is performed, and the preparation has the effects of being free of traces and pain, uniform in injection, and convenient and rapid to use, performing treatment only for 10 min, and achieving the skin beautifying effects of smoothing skin, removing wrinkels, resisting skin aging and the like.
Owner:深圳市旷逸生物科技有限公司
Agent for treating myelofibrosis
ActiveCN102143761AAnti-myelofibrosis effectImprove pathological conditionSpecial deliveryHydroxy compound active ingredientsBone marrow fibrosisRetinoid
Disclosed is a substance delivery carrier for an extracellular-matrix-producing cell in the bone marrow, which comprises a retinoid. Also disclosed is an agent for treating myelofibrosis by utilizing a substance capable of regulating the activity or proliferation of an extracellular-matrix-producing cell in the bone marrow.
Owner:NITTO DENKO CORP
Application of glucogalactooligosaccharide in preparation of medicine for treating and/or preventing ischemia-reperfusion injury
ActiveCN113440540AImprove medicinal effectReduce inflammationOrganic active ingredientsInorganic non-active ingredientsInjury brainGlycan
The invention discloses an application of glucogalactooligosaccharide in preparation of a medicine for treating and / or preventing ischemia-reperfusion injury. The glucogalactooligosaccharide disclosed by the invention can be used for remarkably relieving postoperative liver injury, kidney injury, brain injury and the like of ischemia reperfusion mice, is safe and non-toxic, has a strong drug effect, and has a very good medicinal prospect in prevention and treatment of ischemia reperfusion injury.
Owner:NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD
2-heteroaryl aminoquinazolinone derivative
ActiveUS20210387967A1Suppression of hyperexcitabilityImprove pathological conditionsOrganic chemistry methodsArylChemical compound
Provided is a 2-heteroaryl aminoquinazolinone derivative, which is a compound represented by formula (1):or a pharmaceutically acceptable salt thereofwherein X1 represents CR1 or N, X2 represents CR2 or N, X3 represents CR3 or N, X4 represents CR4 or N, Y represents optionally substituted C1-6 alkyl, an optionally substituted C3-10 alicyclic group, an optionally substituted 4- to 10-membered nitrogen-containing non-aryl heterocycle, optionally substituted C6-10 aryl, or optionally substituted 5- to 10-membered heteroaryl, Z represents optionally substituted 6- to 10-membered heteroaryl, and R1, R2, R3, and R4 each independently represent a hydrogen atom, halogen, cyano, optionally substituted C1-6 alkyl, optionally substituted C1-6 alkoxy, or the like.
Owner:SUMITOMO DAINIPPON PHARMA CO LTD
Application of radix ampelopsis extract in preparation of medicine for preventing and/or treating polycystic ovarian syndrome
PendingCN114259528AImprove pathological conditionImprove efficacySexual disorderEndocrine system disorderDiseasePhysiology
The invention discloses application of a radix ampelopsis extract in preparation of a medicine for preventing and / or treating polycystic ovarian syndrome. The polyovarian syndrome (PCOS) is an endocrine metabolic disease, and the clinical main manifestations are menorrhea or amenorrhea, hyperandrogenesis, polycystic ovarian alteration and the like. On the human body, menstruation can show the ovulation condition of a woman; on the rat body, the ovulation condition of the rat is displayed by the mood cycle. Rats are taken as experimental subjects, a PCOS group, an ampelopsis japonica group and a normal group are set, and the influence of the ampelopsis japonica extract on the PCOS rat physical state is researched by representing the estrus cycle, the ovary state, the sex hormone level, the body mass, the ovary weight, the uterus weight and the like of the rats.
Owner:SOUTHERN MEDICAL UNIVERSITY
Dampness clearing tea and preparation method thereof
PendingCN114468094AImprove pathological conditionEasy to takeMetabolism disorderDigestive systemDiarrheaHerb
The invention discloses dampness-clearing tea and a preparation method thereof, and relates to the field of health-care food. The dampness-clearing tea comprises the following raw materials in parts by weight: 2-5 parts of jasmine flowers; 15 to 20 parts of lotus leaf; 10-14 parts of pericarpium citri reticulatae; 5-8 parts of hyacinth bean flower; 6 to 10 parts of wrinkled gianthyssop herb; 3-7 parts of plum blossom; 12 parts to 17 parts of semen sojae germinatum; and 6-8 parts of fortune eupatorium herb. The formula provided by the invention has an exact curative effect on conditioning the damp-heat constitution, also has a certain effect on treating damp-heat symptoms of diseases such as diarrhea, distention and fullness, hyperlipidemia and hyperglycemia, is easy to prepare, improves the pathological state of the biased constitution on the whole compared with other clinical preparations, and is exact in curative effect, relatively good in taste and free of obvious side effects; and clinical requirements can be well met.
Owner:深圳市宝安区中医院
A strain of Lactobacillus plantarum lp1z that produces lysozyme and efficiently antagonizes multidrug-resistant Helicobacter pylori and its application
ActiveCN114350578BNo side effectsNo residual riskAntibacterial agentsBacteriaBinding siteProbiotic bacterium
The invention discloses a strain of Lactobacillus plantarum LP1Z which produces lysozyme and efficiently antagonizes multidrug-resistant Helicobacter pylori and its application. Lactobacillus plantarum LP1Z, which was preserved in Guangdong Microbial Culture Collection Center on February 21, 2022, address: 5th Floor, Building 59, Compound, No. 100 Xianlie Middle Road, Guangzhou City, Guangdong Province, postcode: 510070, and the preservation number is GDMCC No :62256. (1) The probiotics involved in the present invention can produce various active antibacterial substances such as organic acid and lysozyme, and can effectively inhibit the growth of Helicobacter pylori in the stomach; Colonization, the body can compete with pathogenic bacteria for binding sites, effectively reducing the infection rate of Helicobacter pylori in the stomach; (3) It can improve the pathological state of the stomach and relieve inflammation. Therefore, Lactobacillus plantarum LP1Z has great application prospects in the preparation of products (such as medicines) for preventing or treating Hp infection, especially multidrug-resistant Hp infection.
Owner:GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY +2
Traditional Chinese medicine composition for treating primary biliary cirrhosis and preparation method, dosage form and application of composition
InactiveCN108452050AImprove patient symptomsSimple combinationDigestive systemPlant ingredientsDiuresisPrimary biliary cirrhosis
The invention discloses a traditional Chinese medicine composition for treating primary biliary cirrhosis and a preparation method, dosage form and application of the composition and belongs to the technical field of traditional Chinese medicine and preparations. The traditional Chinese medicine composition is prepared from, by weight, 1,000-3,000 parts of radix rubiae, 800-3,000 parts of herba siegesbeckiae, 800-2,000 parts of radix gentianae macrophyllae, 500-3,000 parts of radix salviae miltiorrhizae, 1,000-2,000 parts of poria cocos and 500-1,500 parts of radix liquiritiae. The traditionalChinese medicine composition has the advantages that the traditional Chinese medicine composition has the main functions of invigorating spleen-stomach, replenishing qi, promoting blood circulation,removing stasis, clearing damp and promoting diuresis and is mainly applied to primary biliary cirrhosis of liver and gall stasis, syndrome of interior dampness-heat and qi stagnation and blood stasis, the human body of a patient with primary biliary cirrhosis can be subjected to overall immune adjustment at the same time, the PBC pathological symptoms can be remarkably improved, and the composition has the advantages of being remarkable in treatment effect, free of toxic or side effect, simple in composition, convenient to prepare, low in cost and the like.
Owner:302 MILITARY HOSPITAL OF CHINA
Orthopedic central machine acupuncture treatment assembly
ActiveCN112932958ARelieve painImprove treatment efficiencyAcupunctureSurgeryAcupuncture treatmentOrthopedic department
The invention discloses an orthopedic central machine acupuncture treatment assembly which comprises a central machine needle and a central machine hammer which are matched with each other; the central machine needle comprises a needle body, an end head and a cutting edge, wherein the end head and the cutting edge are located at the top and the bottom of the needle body respectively; the central machine hammer comprises a hammer head and a hammer handle fixedly connected with the hammer head, and the two ends of the hammer head can knock the end head. The orthopedic central machine acupuncture treatment assembly is easy to operate, low in dependence on the operation technology of doctors, extremely high in safety, good in treatment effect, short in needed treatment time and capable of effectively improving the treatment efficiency and reducing the treatment cost.
Owner:刘然
Chinese medicinal composition for treating fallopian tube obstruction and preparation method thereof
InactiveCN101744921BFast absorptionPromote absorptionAnthropod material medical ingredientsSuppositories deliveryPatriniaNutrition
Owner:赵子山
Senior silkworm excrement external ironing packet for treating diabetes gastroparesis as well as preparation and use method of senior silkworm excrement external ironing packet
ActiveCN110279719AConvenient vomitingImprove nauseaAnthropod material medical ingredientsMetabolism disorderLymphangiectasisGastroparesis
The invention relates to a senior silkworm excrement external ironing packet for treating diabetes gastroparesis as well as a preparation and use method of the senior silkworm excrement external ironing packet. The preparation method comprises the following steps: S1, frying senior silkworm excrement with rice wine so as to obtain a senior silkworm excrement product; S2, uniformly mixing the senior silkworm excrement product with crude salt so as to obtain a senior silkworm excrement mixture; S3, putting the senior silkworm excrement mixture into a cloth bag, thereby obtaining the senior silkworm excrement external ironing packet. The senior silkworm excrement is fried with rice wine and is mixed with the crude salt to make the external ironing packet, the packet is heated for external ironing, absorption of medicinal effects by bodies is promoted through heat, and meanwhile, partial blood vessel expansion and lymphangiectasis of skin can be adjusted and circulation of blood and lymph can be promoted through heat stimulation, so that nutrition metabolism of the bodies can be improved, inflammation reactions can be eliminated, body immunity can be improved, functions of whole bodies can be adjusted, and a function of promoting disease treatment can be achieved. The external ironing packet has the effects of harmonizing stomach and reducing turbidity, activating blood and removing meridian obstruction as well as expelling wind and drying dampness, and with a traditional Chinese medicine instructed massage method, transportation and transformation of spleens and stomachs can be promoted, and catharsis functions of livers can be adjusted.
Owner:北京市房山区中医医院
Application of theacrine in preparation of nerve regeneration agent
InactiveCN104971064AReduce degradationReduce differentiationNervous disorderFood preparationHuntingtons choreaDisease
The invention discloses an application of a compound, theacrine, of which the structure is represented as the formula (I), in preparation of a nerve regeneration agent, and also discloses the nerve regeneration agent of which an active component is the theacrine represented as the structure formula (I). In the invention, it is fully proved that the compound theacrine and a drug, a beverage or food or a health-caring product containing the theacrine can effectively promote nerve regeneration and can provide applications of clinical prevention and treatment and improvement on nerve regeneration-related diseases comprising: Parkinson's disease, Alzheimer's disease, Down syndrome, cerebral vascular disorder, cerebral stroke, spinal cord injury, Huntington's disease, multiple sclerosis, amyotrophic lateralizing sclerosis, epilepsia, anxiety disorder, comprehensive disorder, depression and manic depression and the like.
Owner:何蓉蓉
A kind of traditional Chinese medicine composition for treating hypertensive heart failure
ActiveCN108143800BImprove pathological conditionLower systolic blood pressureCardiovascular disorderPlant ingredientsCaptoprilSalvia miltiorrhiza
The invention discloses a traditional Chinese medicine composition for treating hypertensive heart failure, belonging to the field of traditional Chinese medicines. The raw materials of the traditional Chinese medicine composition include Caulis Spatholobus, Panax notoginseng, Salvia miltiorrhiza, Radix Astragalus, and Citrus Red. The traditional Chinese medicine composition of the present invention conforms to the theory of modern systemic pharmacology, and the selected medicine has clear ingredients that can act on the disease targets of hypertension and heart failure at the same time; at the same time, it conforms to the traditional Chinese medicine syndrome differentiation theory system and the principle of compatibility of monarch, minister, assistant and envoy of Chinese medicine . Experimental results in vivo show that the Chinese medicine composition of the present invention can effectively reduce the systolic blood pressure of SHR in spontaneously hypertensive rats, and the effect is slightly lower than that of the positive control drug captopril; simultaneously, it can improve the ejection fraction and short-axis shortening rate of SHR heart , and the therapeutic effect is better than captopril. The traditional Chinese medicine composition of the invention has the advantages of less medicinal taste, reliable curative effect and clear main medicinal components, which can reduce non-drug efficacy factors in the traditional Chinese medicine compound preparation and improve the preparation level.
Owner:SOUTHERN MEDICAL UNIVERSITY
A traditional Chinese medicine preparation for treating sequelae of pelvic inflammatory disease and its preparation method and application
ActiveCN111905002BReduce chronic pain levelsExcellent adhesionAntibacterial agentsAntimycoticsDiseaseSequela
The invention discloses a traditional Chinese medicine preparation for treating sequelae of pelvic inflammatory disease and a preparation method thereof. Enema mixtures and suppositories made by Lutong. The present invention obtains the prescription through a large number of experimental screenings, and the experimental results show that the Chinese medicine compound composition can reduce the degree of chronic pelvic pain, reduce the pain VAS score and IL-6 level, and improve the symptoms, sign scores and total scores of traditional Chinese medicine. Extensive antibacterial and antibacterial effects can reduce the inflammatory stimulation of pathogens, reduce the expression of inflammatory cytokines such as IL-6 in the body, improve the pathological state of adhesion and scar formation in local pelvic tissues, and have a good effect on the treatment of pelvic inflammatory disease The effect of disease sequelae, and no toxic side effects, safe and reliable medication.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Application of curcumadione combined with ginkgoic acid in the preparation of drugs for promoting bone formation
ActiveCN111991405BPromote differentiationPromote regenerationSalicyclic acid active ingredientsSkeletal disorderBULK ACTIVE INGREDIENTPharmaceutical Substances
The invention relates to a new application of curcumadione combined with ginkgoic acid, in particular to the application of curcumadione combined with ginkgoic acid in preparing a drug for promoting bone formation. The combination of curedione and ginkgoic acid can significantly promote the differentiation of mesenchymal stem cells into osteoblasts and promote osteogenesis. The osteogenesis-promoting drug prepared with it as the active ingredient can promote the differentiation of mesenchymal stem cells into osteoblasts. Differentiate and promote the osteogenesis of osteoblasts, promote bone regeneration, and improve the pathological state of slow bone regeneration. As an effective treatment plan for fractures and osteoporosis, a new application has been developed for curcumadione combined with ginkgoic acid preparations, and it also provides new therapeutic drugs for patients with fractures and osteoporosis. Therapy offers new approaches.
Owner:THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU UNIV OF CHINESE MEDICINE
Traditional Chinese medicine composition for influencing gastric mucosa oncogene expression level
ActiveCN114470116AImprove intestinal digestionImprove chronic inflammationDigestive systemPlant ingredientsRadix Astragali seu HedysariSemen
The invention belongs to the field of application of a traditional Chinese medicine in treating diseases caused by the influence of the expression level of an oncogene mutant p53 and an oncogene MDM2 on the gastric mucosa of a patient, and particularly relates to specific application of the traditional Chinese medicine in the diseases caused by the mechanism, such as chronic atrophic gastritis. According to the technical scheme, the traditional Chinese medicine composition capable of influencing the oncogene expression level of the gastric mucosa is prepared from the following components in parts by weight: 400 to 3000 parts of radix astragali seu hedysari, 500 to 1500 parts of lucid ganoderma, 300 to 4000 parts of semen coicis, 500 to 1500 parts of pericarpium citri reticulatae, 300 to 4000 parts of herba salviae chinensis and 300 to 4000 parts of herba hedyotidis diffusae. Immunohistochemical analysis shows that by inhibiting expression correlation of oncogene mutant p53 and MDM2, the medicine has a good curative effect on patients with chronic atrophic gastritis, and particularly has a better curative effect on improving gastral cavity fullness or dull pain, stomach pressing or warming, thin stool, lassitude and weakness, short breath and laziness to speak and the like compared with a gold standard medicine morhodamine; the pathological states of gastric mucosa atrophy, intestinal metaplasia, chronic inflammation, activity and the like can be effectively improved, and the atrophy process is delayed.
Owner:南京市溧水区中医院
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com